| Amount | Holding |
|---|---|
| 20.93% | Novo Nordisk A/s-b |
| 7.67% | DSV Panalpina A/S |
| 6.54% | Orsted A/S |
| 5.79% | Genmab A/S |
| 4.55% | Vestas Wind Systems A/S |
| 4.35% | Carlsberg As-b |
| 4.20% | Coloplast-b |
| 3.95% | Novozymes A/s-b Shares |
| 3.39% | Chr. Hansen Holding A/S |
| 3.04% | Danske Bank A/S |
Diversification Rating
0 /10
Expense Ratio Rating
6 /10
Expense Rating
5 /10
Market Score
5 /10
Category Score
5 /10
Market Size
5 /10
$EDEN Alternatives
49%
FI Score
- eden
- ETF
- International Stocks
- Other Region
Expenses: 0.53% (Better than 1% of similar funds)
This is a bad choice for a Other Region International Stocks fund. See why ยป